Real-time Estimate
Other stock markets
|
||
99.21 CHF | 0.00% |
|
07:43pm | Novartis to Close Technical Research Facility in San Diego, California; 100 Jobs Affected | MT |
04:28pm | Novartis to Close Research Facility in San Diego, California; 100 Jobs Affected | MT |
Sales 2024 * | 49.24B 44.08B | Sales 2025 * | 51.39B 46B | Capitalization | 227B 203B |
---|---|---|---|---|---|
Net income 2024 * | 10.73B 9.6B | Net income 2025 * | 12.02B 10.76B | EV / Sales 2024 * | 4.87 x |
Net Debt 2024 * | 13.29B 11.9B | Net Debt 2025 * | 11.62B 10.4B | EV / Sales 2025 * | 4.64 x |
P/E ratio 2024 * |
21.3
x | P/E ratio 2025 * |
18.4
x | Employees | - |
Yield 2024 * |
3.31% | Yield 2025 * |
3.43% | Free-Float | 85.22% |
Latest transcript on Novartis AG
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 04-12-31 | |
Director of Finance/CFO | 59 | 02-12-31 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 22-05-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 12-12-31 |
Simon Moroney
BRD | Director/Board Member | 65 | 20-02-27 |
Chairman | 68 | 12-12-31 |
1st Jan change | Capi. | |
---|---|---|
+60.25% | 846B | |
+38.56% | 628B | |
-4.49% | 360B | |
+18.30% | 322B | |
+9.64% | 297B | |
+14.15% | 240B | |
+3.11% | 224B | |
+12.87% | 173B | |
-0.45% | 161B |